Eidos Therapeutics Inc (OQ:EIDX)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for EIDX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Jul 3/18 Jul 1/18 Aguiar Eric Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 43,056  
Jul 3/18 Jul 1/18 Shah Rajeev M. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 43,056  
Jul 3/18 Jul 1/18 Satvat Ali J. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 43,056  
Jun 22/18 Jun 22/18 Ra Capital Management, Llc Indirect Ownership Series B Convertible Preferred Stock C - Conversion -922,950  
Jun 22/18 Jun 22/18 Ra Capital Management, Llc Indirect Ownership Common Stock P - Open market or private purchase 1,058,824 $17.00
Jun 22/18 Jun 22/18 Ra Capital Management, Llc Indirect Ownership Common Stock C - Conversion 1,103,847  
Jun 26/18 Jun 22/18 BridgeBio Pharma LLC Direct Ownership Series Seed Preferred Stock C - Conversion -12,832,123  
Jun 26/18 Jun 22/18 BridgeBio Pharma LLC Direct Ownership Series B Preferred Stock C - Conversion -2,909,029  
Jun 26/18 Jun 22/18 BridgeBio Pharma LLC Direct Ownership Series B Preferred Stock X - in- or at-the-money exercise 332,262  
Jun 26/18 Jun 22/18 BridgeBio Pharma LLC Direct Ownership Warrants X - in- or at-the-money exercise -332,262  
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for EIDX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Jul 3/18 Jul 1/18 Aguiar Eric Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 43,056  
Jul 3/18 Jul 1/18 Shah Rajeev M. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 43,056  
Jul 3/18 Jul 1/18 Satvat Ali J. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 43,056  
Jun 26/18 Jun 22/18 BridgeBio Pharma LLC Direct Ownership Series Seed Preferred Stock C - Conversion -12,832,123  
Jun 26/18 Jun 22/18 BridgeBio Pharma LLC Direct Ownership Series B Preferred Stock C - Conversion -2,909,029  
Jun 26/18 Jun 22/18 BridgeBio Pharma LLC Direct Ownership Series B Preferred Stock X - in- or at-the-money exercise 332,262  
Jun 26/18 Jun 22/18 BridgeBio Pharma LLC Direct Ownership Warrants X - in- or at-the-money exercise -332,262  
Jun 26/18 Jun 22/18 BridgeBio Pharma LLC Direct Ownership Common Stock P - Open market or private purchase 1,000,000 $17.00
Jun 26/18 Jun 22/18 BridgeBio Pharma LLC Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -211,762 $17.00
Jun 26/18 Jun 22/18 BridgeBio Pharma LLC Direct Ownership Common Stock C - Conversion 18,826,417  
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $EIDX

StockTwits